8q24.3 microdeletion syndrome
eight q twenty-four point three microdeletion syndrome
Also known as: 8q24.3 contiguous gene syndrome, 8q24.3 deletion syndrome
At a Glance
What is 8q24.3 microdeletion syndrome?
8q24.3 microdeletion syndrome is a rare genetic disorder caused by the deletion of a small piece of chromosome 8. It primarily affects the neurological and cardiovascular systems. The condition is present from birth and can lead to developmental delays and intellectual disabilities. Early symptoms may include feeding difficulties and poor muscle tone, while later symptoms can involve learning disabilities and heart defects. Early diagnosis is crucial to manage symptoms and improve quality of life. The syndrome can significantly impact family life due to the need for ongoing medical care and support. Prognosis varies depending on the severity of symptoms and associated health issues. Daily life for affected individuals often involves special education and therapies to aid development. The condition is usually caused by a spontaneous genetic mutation, though it can sometimes be inherited. Families may require genetic counseling to understand the risks and implications. Individuals with this syndrome may face challenges in social interactions and require assistance with daily activities. Despite these challenges, many affected individuals can lead fulfilling lives with appropriate support.
Medical Definition
8q24.3 microdeletion syndrome is characterized by the deletion of genetic material on the long arm of chromosome 8 at position 24.3. Pathological mechanisms involve the loss of multiple genes, including NAA15 and PUF60, which are implicated in intellectual disability and developmental anomalies. Histological findings may include abnormalities in brain and cardiac tissues. The syndrome is classified under chromosomal deletion syndromes and is part of the broader category of genetic disorders. Epidemiologically, it is considered a rare condition with few documented cases in medical literature. The disease course is variable, with symptoms ranging from mild to severe, and management focuses on symptomatic treatment and supportive care.
8q24.3 microdeletion syndrome Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Intellectual disability in 8q24.3 microdeletion syndrome manifests as developmental delays and learning difficulties. This is caused by the deletion of genes critical for cognitive development, such as PUF60. Over time, the degree of intellectual disability can range from mild to severe, impacting educational attainment and social interactions. Early intervention with special education and therapies can help improve cognitive skills and quality of life.
Short stature is often observed in individuals with this syndrome, characterized by a height significantly below average for age and sex. The biological mechanism involves disruptions in growth-related genes within the deleted region. As the child grows, the short stature becomes more pronounced, potentially affecting self-esteem and social experiences. Growth hormone therapy may be considered to help achieve a more typical height.
Heart defects, such as atrial septal defects, are common and can be detected via echocardiogram. These defects arise from the improper development of cardiac structures due to gene deletions. If untreated, heart defects can lead to complications like heart failure or arrhythmias over time. Surgical intervention or medical management is often necessary to correct the defects and improve cardiac function.
Common
Facial dysmorphism includes features such as a broad forehead, wide-set eyes, and a flat nasal bridge. These features result from the altered development of craniofacial structures due to genetic deletions. As the individual ages, these distinctive features may become more pronounced. While they do not typically affect health, they can influence social interactions and self-image, with supportive counseling being beneficial.
Speech delay is characterized by a slower acquisition of language skills compared to peers. This is due to the impact of the genetic deletion on brain regions involved in language processing. Over time, speech delays can affect communication and academic performance. Speech therapy can significantly aid in developing language skills and improving communication abilities.
Hypotonia presents as decreased muscle tone, leading to floppiness and delayed motor skills. It is caused by disruptions in neuromuscular pathways due to the genetic deletion. Over time, hypotonia can affect posture, balance, and coordination, impacting daily activities. Physical therapy can help strengthen muscles and improve motor function.
Less Common
Seizures may occur in some individuals, manifesting as episodes of abnormal electrical activity in the brain. This is linked to the deletion of genes involved in neuronal function. Seizures can vary in frequency and severity, potentially affecting safety and quality of life. Antiepileptic medications and regular monitoring can help manage seizure activity.
Feeding difficulties can include problems with sucking, swallowing, or digesting food. These issues arise from hypotonia or structural anomalies in the gastrointestinal tract. Over time, feeding difficulties can lead to nutritional deficiencies and growth concerns. Nutritional support and feeding therapy can assist in ensuring adequate intake and growth.
What Causes 8q24.3 microdeletion syndrome?
8q24.3 microdeletion syndrome is primarily caused by deletions in the chromosomal region 8q24.3, which includes genes such as NAA15 and PUF60. NAA15 encodes a subunit of the N-terminal acetyltransferase complex, which is involved in protein acetylation, a critical post-translational modification. PUF60 encodes a splicing factor that is essential for the proper processing of pre-mRNA. Mutations or deletions in these genes can lead to loss of function or altered function of the encoded proteins. This disruption can result in improper protein acetylation and splicing, affecting cellular homeostasis. Consequently, there is a cascade of molecular dysfunctions, including impaired RNA processing and protein synthesis. These molecular aberrations can lead to dysfunction in cellular organelles such as the endoplasmic reticulum and mitochondria. The downstream effects include altered cell signaling and communication, particularly affecting neurons and cardiac cells. Neuroinflammation may be triggered as a response to cellular stress and damage, exacerbating neuronal dysfunction. Over time, this can contribute to the degeneration of white matter and other critical brain structures. The clinical symptoms, including intellectual disability, heart defects, and short stature, arise due to the specific cellular and tissue dysfunctions. The variability in disease severity among patients is likely due to the extent of the deletion and the presence of additional genetic or environmental factors. The pattern of symptoms reflects the specific roles of the affected genes in neural development and cardiac function.
How is 8q24.3 microdeletion syndrome Diagnosed?
Typical age of diagnosis: 8q24.3 microdeletion syndrome is typically diagnosed in early childhood when developmental delays become apparent, often following a referral to a specialist due to concerns about growth, intellectual development, or congenital anomalies.
Clinicians look for signs of developmental delay, intellectual disability, and congenital anomalies such as heart defects and short stature. A detailed family history is important to identify any hereditary patterns or similar conditions in relatives. Physical examination may reveal dysmorphic features, growth abnormalities, or other congenital malformations. This step helps to determine the need for further genetic testing and rule out other syndromes with overlapping features.
Magnetic Resonance Imaging (MRI) of the brain is often used to detect structural abnormalities. Specific abnormalities such as ventriculomegaly or corpus callosum agenesis may be visible, supporting the diagnosis. These findings can confirm the presence of neurological involvement and help exclude other conditions like isolated hydrocephalus. Imaging results are integrated with clinical findings to strengthen the suspicion of a genetic syndrome.
Basic laboratory tests may include metabolic screening and thyroid function tests. Biomarkers such as elevated lactate or abnormal thyroid levels could indicate metabolic or endocrine involvement. Abnormal results prompt further investigation into specific organ systems or metabolic pathways. These tests guide the clinician in managing symptoms and deciding on the urgency of genetic testing.
Genetic testing involves sequencing the 8q24.3 region to identify deletions or mutations in genes like PUF60. Deletions or mutations in this region confirm the diagnosis of 8q24.3 microdeletion syndrome. Results provide a definitive diagnosis and are crucial for genetic counseling of the family. Genetic findings inform decisions on family planning and the risk of recurrence in future pregnancies.
8q24.3 microdeletion syndrome Treatment Options
Stimulant medications such as methylphenidate are used to manage attention deficit symptoms. These drugs work by increasing dopamine and norepinephrine levels in the brain, improving focus and behavior. Clinical trials have shown efficacy in improving attention span and reducing hyperactivity in affected individuals. Side effects can include decreased appetite, sleep disturbances, and potential cardiovascular effects. Regular monitoring and dose adjustments are necessary to minimize side effects and maximize therapeutic benefits.
Techniques such as motor skill exercises and balance training are employed to improve physical development. The goal is to enhance motor skills, coordination, and muscle strength. Sessions are typically conducted 2-3 times a week for 30-60 minutes each. Measurable outcomes include improved gross motor function and increased independence in daily activities. Long-term benefits include better physical health and reduced risk of secondary complications.
Indicated for congenital heart defects such as septal defects or valve abnormalities. The procedure involves repairing or replacing defective heart structures to improve cardiac function. Expected benefits include improved circulation and reduced symptoms of heart failure. Surgical risks include infection, bleeding, and anesthesia-related complications. Post-operative care requires monitoring in a specialized cardiac unit and long-term follow-up with a cardiologist.
The care team typically includes a geneticist, neurologist, cardiologist, and developmental therapist. Interventions focus on individualized education plans, behavioral therapy, and nutritional support. Psychosocial support strategies involve counseling and support groups for families. Family education is crucial for understanding the condition and managing expectations. Long-term monitoring includes regular assessments of growth, development, and organ function.
When to See a Doctor for 8q24.3 microdeletion syndrome
- Severe difficulty breathing — this may indicate a serious cardiac or respiratory issue requiring immediate medical attention.
- Sudden loss of consciousness — could be a sign of a critical neurological event or severe cardiac problem.
- Seizures — these can indicate a serious neurological condition that needs urgent evaluation and management.
- Developmental delays — important to assess and intervene early to optimize outcomes.
- Heart murmurs — may indicate underlying cardiac defects that require further investigation.
- Unexplained short stature — could be a sign of growth hormone deficiency or other systemic issues needing evaluation.
- Mild learning difficulties — monitor progress and seek educational support as needed.
- Occasional headaches — track frequency and triggers, consult a doctor if they worsen.
8q24.3 microdeletion syndrome — Frequently Asked Questions
Is this condition hereditary?
8q24.3 microdeletion syndrome can be hereditary, often following an autosomal dominant pattern. There is a 50% chance of passing the condition to offspring if a parent is affected. De novo mutations, which occur spontaneously, are also possible. Carrier status implications are significant, as carriers can pass the deletion to their children. Genetic counseling is recommended for affected families to understand inheritance patterns and reproductive options.
What is the life expectancy for someone with this condition?
Life expectancy can vary depending on the severity of symptoms and associated complications. Early onset with severe cardiac or neurological issues may worsen prognosis. Mortality is often related to cardiac defects or severe infections. Treatment and regular monitoring can improve quality of life and survival. Realistic expectations involve managing symptoms and optimizing health through multidisciplinary care.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis typically involves genetic testing, such as chromosomal microarray analysis, to identify the deletion. The time from first symptoms to diagnosis can vary, often taking months to years due to symptom variability. Specialists such as geneticists, cardiologists, and neurologists are commonly involved. Delayed diagnosis may occur due to the rarity of the condition and overlapping symptoms with other disorders. Confirmation is achieved through genetic testing results.
Are there any new treatments or clinical trials available?
Current research is exploring gene therapy and targeted molecular treatments as potential options. Novel approaches focus on addressing specific genetic and symptomatic aspects of the syndrome. ClinicalTrials.gov is a resource for finding ongoing trials related to 8q24.3 microdeletion syndrome. Patients should discuss potential trial participation with their healthcare provider. New treatments may take several years to become widely available.
How does this condition affect daily life and activities?
The condition can impact mobility and self-care, depending on the severity of physical symptoms. Educational challenges are common, requiring tailored learning strategies and support. Social and emotional challenges may arise due to developmental delays and physical limitations. Family burden can be significant, necessitating support and resources. Adaptive equipment and therapies can greatly assist in daily functioning and quality of life.
Learn More
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.Exome sequencing reveals NAA15 and PUF60 as candidate genes associated with intellectual disability.
Zhao JJ, Halvardson J, Zander CS et al. · Am J Med Genet B Neuropsychiatr Genet · 2018 · PMID: 28990276
- 2.Dominant variants in the splicing factor PUF60 cause a recognizable syndrome with intellectual disability, heart defects and short stature.
El Chehadeh S, Kerstjens-Frederikse WS, Thevenon J et al. · Eur J Hum Genet · 2016 · PMID: 27804958
- 3.First fetal case of the 8q24.3 contiguous genes syndrome.
Wells C, Spaggiari E, Malan V et al. · Am J Med Genet A · 2016 · PMID: 26437074
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-06-01